Xavière Panhard

782 total citations
18 papers, 526 citations indexed

About

Xavière Panhard is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Xavière Panhard has authored 18 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Xavière Panhard's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Xavière Panhard is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Xavière Panhard collaborates with scholars based in France, United States and New Zealand. Xavière Panhard's co-authors include France Mentré, B. Fantin, A. Lefort, Olivier Clermont, Érick Denamur, Michel Wolff, Catherine Branger, Paul‐Louis Woerther, Cécile Goujard and Anne‐Laure Samson and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and The Journal of Urology.

In The Last Decade

Xavière Panhard

18 papers receiving 509 citations

Peers

Countries citing papers authored by Xavière Panhard

Since Specialization

Citations

This map shows the geographic impact of Xavière Panhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavière Panhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavière Panhard more than expected).

Fields of papers citing papers by Xavière Panhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavière Panhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavière Panhard. The network helps show where Xavière Panhard may publish in the future.

Co-authorship network of co-authors of Xavière Panhard

This figure shows the co-authorship network connecting the top 25 collaborators of Xavière Panhard. A scholar is included among the top collaborators of Xavière Panhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavière Panhard. Xavière Panhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France 2017 ·Medicine ·C Richaud, Victoire de Lastours, Xavière Panhard, David Petrover, B. Fantin, A. Lefort	17
2	Escherichia colibacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome 2014 ·Epidemiology and Infection ·(unknown), Xavière Panhard, Olivier Clermont, France Mentré, B. Fantin, Érick Denamur, A. Lefort	17
3	Adherence Profiles and Therapeutic Responses of Treatment-Naive HIV-Infected Patients Starting Boosted Atazanavir-Based Therapy in the ANRS 134-COPHAR 3 Trial 2013 ·Antimicrobial Agents and Chemotherapy ·Jean‐Jacques Parienti, Aurélie Barrail‐Tran, Xavier Duval, (unknown), Diane Descamps, Marie Vigan, Bernard Vrijens, Xavière Panhard, Anne‐Marie Taburet, France Mentré, Cécile Goujard	27
4	Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients 2012 ·Clinical Pharmacology & Therapeutics ·Radojka M. Savić, Aurélie Barrail‐Tran, Xavier Duval, (unknown), Xavière Panhard, Diane Descamps, Céline Verstuyft, Bernard Vrijens, (unknown), Cécile Goujard, France Mentré	40
5	Role of hepatic HCV–RNA level on the severity of chronic hepatitis C and response to antiviral therapy 2011 ·Journal of Clinical Virology ·Sarah Maylin, Cédric Laouenan, Michelle Martinot-Peignoux, Xavière Panhard, Martine Lapalus, M.‐H. Nicolas‐Chanoine, Pierre Bédossa, Tarik Asselah, Patrick Marcellin	3
6	Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features 2010 ·Clinical Microbiology and Infection ·(unknown), A. Lefort, Xavière Panhard, Olivier Clermont, Quentin Dornic, B. Fantin, France Mentré, Michel Wolff, Érick Denamur, Catherine Branger	62
7	Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia 2010 ·Journal of Clinical Microbiology ·A. Lefort, Xavière Panhard, Olivier Clermont, Paul‐Louis Woerther, Catherine Branger, France Mentré, B. Fantin, Michel Wolff, Érick Denamur	109
8	Benefit of therapeutic drug monitoring of protease inhibitors in HIV‐infected patients depends on PI used in HAART regimen – ANRS 111 trial 2009 ·Fundamental and Clinical Pharmacology ·Xavier Duval, France Mentré, Elisabeth Rey, (unknown), Gilles Peytavin, M Biour, (unknown), Cécile Goujard, Anne‐Marie Taburet, (unknown), Xavière Panhard, Jean‐Marc Tréluyer, Dominique Salmon, (unknown)	11
9	Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART 2009 ·European Journal of Clinical Pharmacology ·(unknown), Julie Bertrand, Jean‐Marc Tréluyer, Xavière Panhard, Agnès Tran, (unknown), Elisabeth Rey, Dominique Salmon‐Céron, Xavier Duval, France Mentré	27
10	Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects 2008 ·Biostatistics ·Xavière Panhard, Anne‐Laure Samson	22
11	Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis 2008 ·Clinical Microbiology and Infection ·F. Bert, Xavière Panhard, James R. Johnson, Hervé Lécuyer, Richard Moreau, (unknown), (unknown), (unknown), Dominique Valla, M.‐H. Nicolas‐Chanoine	21
12	The 20-Core Prostate Biopsy Protocol—A New Gold Standard? 2008 ·The Journal of Urology ·V. Ravery, (unknown), Xavière Panhard, M Toublanc, Liliane Boccon‐Gibod, L Boccon-Gibod	40
13	Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART 2007 ·European Journal of Clinical Pharmacology ·Xavière Panhard, (unknown), Anne‐Marie Taburet, Bertrand Diquet, Cécile Goujard, France Mentré, (unknown)	25
14	Impact of modelling intra‐subject variability on tests based on non‐linear mixed‐effects models in cross‐over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients 2006 ·Statistics in Medicine ·Xavière Panhard, Anne‐Marie Taburet, (unknown), France Mentré	11
15	Evaluation by simulation of tests based on non‐linear mixed‐effects models in pharmacokinetic interaction and bioequivalence cross‐over trials 2005 ·Statistics in Medicine ·Xavière Panhard, France Mentré	36
16	Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART 2005 ·British Journal of Clinical Pharmacology ·Xavière Panhard, Cécile Goujard, (unknown), Anne Marie Taburet, B. Diquet, France Mentré, (unknown)	14
17	Enhanced Saquinavir Exposure in Human Immunodeficiency Virus Type 1-Infected Patients with Diarrhea and/or Wasting Syndrome 2004 ·Antimicrobial Agents and Chemotherapy ·Hervé Trout, France Mentré, Xavière Panhard, (unknown), L. Escaut, Pascal Pernet, Jean‐Gérard Gobert, Daniel Vittecoq, (unknown), C Caulin, Jean‐François Bergmann	15
18	Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments 2003 ·Antimicrobial Agents and Chemotherapy ·Anne‐Claude Crémieux, Claudette Muller‐Serieys, Xavière Panhard, Frédérique Delatour, (unknown), France Mentré, Antoine Andremont	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact